Lipitor Appetite & Cravings Changes: What Atorvastatin Does (and Doesn't Do) to Hunger
At a glance
- Drug / atorvastatin (Lipitor), HMG-CoA reductase inhibitor (statin), prescription only [1][2]
- Appetite loss or anorexia in the label / not listed in the trial adverse-reaction table [1]
- Nausea in placebo-controlled trials / 4.0% atorvastatin vs 3.5% placebo [1]
- Diarrhea / 6.8% vs 6.3% placebo [1]
- Stopping for nausea / 0.4% of Lipitor-treated patients, more often than placebo [1]
- Trial database behind those numbers / 17 placebo-controlled trials, 8,755 vs 7,311 patients, median 53 weeks [1]
- How it is taken / once daily, any time of day, with or without food [1]
Does atorvastatin change appetite?
Appetite changes are not listed in the Lipitor label's placebo-controlled trial adverse-reaction table [1]. That table reports reactions that occurred in at least 2% of atorvastatin-treated patients and more often than on placebo, so it captures common complaints rather than every event recorded in those trials [1].
Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. In animal models, it also increases the number of hepatic LDL receptors, which helps clear LDL from the blood [1]. The label's mechanism description does not mention hunger or appetite [1].
What the Lipitor label actually reports
The label's side-effect table pools 17 placebo-controlled trials: 8,755 patients on atorvastatin at any dose and 7,311 on placebo, median treatment 53 weeks [1]. The gastrointestinal entries are modest and close to placebo:
- Nausea: 4.0% on atorvastatin vs 3.5% on placebo [1]
- Diarrhea: 6.8% vs 6.3% [1]
- Dyspepsia: 4.7% vs 4.3% [1]
Nausea led 0.4% of Lipitor-treated patients to stop treatment, and it was a reason for stopping more often than with placebo, behind myalgia at 0.7% and diarrhea at 0.5% [1]. The label keeps a separate list of other reactions seen in the same placebo-controlled trials, including abdominal discomfort, eructation, flatulence, malaise and pyrexia; decreased appetite is not named there either [1].
Weight and blood sugar
Weight gain is not listed among the reactions in the label's placebo-controlled trial table [1]. The label does say that HbA1c and fasting serum glucose increases have been reported with statins, including atorvastatin [1]. In SPARCL, diabetes was reported as an adverse reaction in 6.1% of patients on atorvastatin 80 mg versus 3.8% on placebo [1].
Taking it with food, and whether timing matters
The label says to take atorvastatin once daily at any time of day, with or without food, and that LDL reduction is the same with or without food and at any time of day [1]. The label also says to avoid large quantities of grapefruit juice, more than 1.2 liters daily [1].
Frequently asked questions
Does Lipitor make you lose your appetite?
Does atorvastatin cause food cravings or increased hunger?
Does atorvastatin cause weight gain?
Why do I feel sick after taking atorvastatin?
Does grapefruit make atorvastatin side effects worse?
Does the time of day change how atorvastatin feels?
References
- U.S. National Library of Medicine, DailyMed. Lipitor atorvastatin calcium tablets (Viatris Specialty) prescribing information. Lipitor atorvastatin calcium tablets (Viatris Specialty) label
- Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
- Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361(9364):1149-58. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial